Skip Navigation
Skip Website Tools

Contact Us

If you are interested in volunteering to participate in a clinical study, please call or email us.
Phone:
866-833-LIFE (866-833-5433)
Email: vaccines@nih.gov

Getting to the VRC Clinic

View maps and directions to the VRC clinic or take a Virtual Tour of VRC Clinic (Real Player)

VRC Vaccine Research Studies

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Current Vaccine Clinical Studies

We are currently enrolling volunteers for a range of studies. If you are interested in volunteering to participate in a clinical trial, call 866-833-LIFE (866-833-5433), email vaccines@nih.gov, or fill out a confidential Volunteer Questionnaire.

Studies Open to Accrual

VRC 500 (11-I-0164):
Screening of Volunteers for Clinical Trials of Investigational Products and Licensed Products Evaluated for Research Purposes

VRC 207 (14-I-0183)
A Phase 1/1b, Open-Label, Dose-Escalation Clinical Trial to Evaluate the Safety, Tolerability and Immunogenicity of the Ebola Chimpanzee Adenovirus Vector Vaccines VRC-EBOADC069-00-VP (cAd3-EBO), and VRC-EBOADC076-00-VP (cAd3-EBOZ), in Healthy Adults

VRC 314 (14-I-0035):
A Phase 1, Open-Label, Clinical Trial With Experimental Controlled Human Malaria Infections (CHMI) to Evaluate Safety and Durability of Protection Following Intravenous and Intramuscular Administration of PFSPZ Vaccine in Malaria-Naive Adults

VRC 315 (14-I-0160)
A Phase I Open-Label, Randomized Study of H7 Influenza Prime-Boost Regimens in Healthy Adults: Recombinant H7 DNA Plasmid Vaccine, VRC-FLUDNA071-00-VP, Administered Alone or With Monovalent Influenza Subunit Virion H7N9 Vaccine (MIV) as Prime With MIV Boost Compared to MIV Prime With MIV Boost

VRC 601 (13-I-0189):
A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC HIVMAB060-00-AB (VRC01), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to HIV-Infected Adults

VRC 900 (10-I-0109):
Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and Older

VRC 200 (03-I-0263):
Apheresis Procedures to Obtain Plasma or Peripheral Blood Mononuclear Cells (PBMCs) for Research Studies

back to top

Last Updated December 17, 2014

Last Reviewed September 27, 2010